急性多器官功能障碍(aMOD)的布莱顿协作病例定义及免疫安全数据收集指南
本文介绍布莱顿协作组织新制定的急性多器官功能障碍(aMOD)作为免疫接种后不良事件(AEFI)的病例定义,适用于临床试验和上市后药物警戒。该定义基于文献范围综述和专家共识,针对六个器官系统设定五个诊断确定性等级,旨在标准化AEFI病例确认以促进疫苗安全数据可比性。
要点
- aMOD定义为呼吸、心血管、肾脏、神经、肝脏和止血六个器官系统中两个或以上出现急性功能障碍。
- 器官功能障碍需在同一临床事件内发生,起病在7天内,可序贯或同时受累。
- 每个器官系统设有五个诊断确定性等级,整体病例定义分为肯定、很可能、可能、信息不足和非病例五级。
核心结论
- 布莱顿协作组织发布了aMOD作为AEFI的标准化病例定义,包含五个诊断确定性等级,旨在促进疫苗安全数据的可比性。
研究设计与样本
- 该病例定义由主题专家和布莱顿协作流程专家组成的团队制定,属于CEPI资助的SPEAC项目的一部分。
- 制定过程包括文献范围综述和专家共识,并经过疫苗安全利益相关者和aMOD专家的同行评审。
主要发现
- aMOD定义为涉及呼吸、心血管、肾脏、神经、肝脏和止血六个器官系统中两个或以上的急性功能障碍。
- 器官功能障碍需在同一临床事件内发生,起病在7天内,可序贯或同时受累。
- 每个器官系统设有五个诊断确定性等级,整体aMOD病例定义也包含五个诊断确定性类别:1级(肯定)、2级(很可能)、3级(可能)、4级(信息不足)和5级(非病例)。
关键数值与推荐
- aMOD病例定义要求两个或以上器官系统出现急性功能障碍,且起病在7天内。
- 每个器官系统有五个诊断确定性等级,整体病例定义分为五个诊断确定性类别。
临床怎么用
- 该病例定义可用于临床试验和上市后药物警戒中标准化aMOD病例确认,促进不同设置和研究间AEFI监测数据的比较。
- 不用于指导临床管理,但可作为疫苗效力和效果研究中疾病严重程度的结局指标。
- AEFI病例定义与因果关系评估分开,使用时应遵循此原则。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This is a new Brighton Collaboration case definition of acute multi-organ dysfunction (aMOD) as an adverse event following immunization (AEFI). It is intended for use in clinical trials and post-licensure pharmacovigilance activities to facilitate safety data comparability across multiple settings. It is not intended to guide clinical management, but it can serve as an outcome measure of disease severity in the context of vaccine efficacy and effectiveness studies. The case definition was developed by a group of subject matter and Brighton Collaboration process experts as part of the Coalition for Epidemic Preparedness Innovations (CEPI)-funded Safety Platform for Evaluation of vACcines (SPEAC). The Brighton Collaboration case definition includes a scoping review of the literature and expert consensus used to define levels of diagnostic certainty (LOC) for aMOD and provides specific guidelines for related data collection and analysis. The document underwent peer review by a Reference Group of vaccine safety stakeholders and aMOD experts to ensure case definition useability, applicability, and scientific integrity. aMOD is defined as acute dysfunction involving two or more of six organ systems: respiratory, cardiovascular, renal, neurologic, hepatic, and hemostatic. A key feature is the requirement that organ dysfunction occur within the same clinical episode, with onset within 7 days, allowing sequential or simultaneous involvement. Five LOC are included for each of the six organs. The overall aMOD case definition also comprises five LOC categories: Level 1 (Definite), Level 2 (Probable), Level 3 (Possible), Level 4 (Insufficient information), and Level 5 (Not a case). The criteria build on established organ dysfunction frameworks while adapting them for global application. Importantly, AEFI case definitions are separate from causality assessment. This case definition provides a standardized approach to aMOD case ascertainment, bridging concepts of organ dysfunction with Brighton Collaboration requirements for reproducible vaccine safety assessment. It also provides a standard case definition that can be used by stakeholders to harmonize assessment of AEFI to enable rigorous analysis and comparison of AEFI surveillance across settings and studies.
引用
- O'Connor C, Jacob ST, Levy JH, et al. Acute multi-organ dysfunction (aMOD): Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2026. PMID: 42963301. doi:10.1016/j.vaccine.2026.129264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。